Center on Aging
Mark S. Kindy, Ph.D.
- Associate Director and Executive Committee Member
- Admiral Pihl Professor, Department of Neurosciences
The molecular basis of disease. Identification of novel targets for drug therapy. Specifically, understanding the amyloid formation in Alzheimer's disease, identifying signal transduction pathways in stroke and spinal cord injury. The primary goal of the laboratory is to determine the underlying mechanisms of these diseases and identify targets and compounds for treatment.